Group 1 - The company stated that information regarding its lithium iodide product partners is considered a trade secret and cannot be disclosed publicly [1] - Product pricing is adjusted based on market supply and demand factors, following industry practices [1]

Core Viewpoint - 博苑股份 has seen a significant decrease in the number of shareholders, indicating a potential shift in investor sentiment and market dynamics [1] Shareholder Information - As of November 10, the number of shareholders for 博苑股份 was 11,873, a decrease of 1,755 from the previous period (October 31), representing a decline of 12.88% [1] Stock Performance - The closing price of 博苑股份 on the reporting date was 86.25 yuan, reflecting an increase of 1.35%. However, since the beginning of the current concentration period, the stock price has cumulatively decreased by 5.93%, with 4 days of increases and 4 days of decreases [1] Margin Trading Data - The latest margin trading balance for 博苑股份 as of November 11 was 167 million yuan, with the financing balance also at 167 million yuan. During the current concentration period, the financing balance has decreased by 34.0651 million yuan, a decline of 16.95% [1] Financial Performance - According to the third-quarter report, 博苑股份 achieved a total operating revenue of 1.073 billion yuan in the first three quarters, representing a year-on-year growth of 6.60%. However, net profit was 132 million yuan, showing a year-on-year decline of 22.41%. The basic earnings per share were 0.9912 yuan, and the weighted average return on equity was 7.93% [1]

Group 1 - The core viewpoint of the news is that Boyuan Co., Ltd. (SZ 301617) is actively engaging with investors, indicating a focus on transparency and communication regarding its business operations [1] - Boyuan Co., Ltd. will participate in an investor research meeting on November 12, 2025, with key executives including the Executive Vice President, Secretary of the Board, Chief Financial Officer, and Securities Affairs Representative present to address investor inquiries [1] - As of the latest report, Boyuan Co., Ltd. has a market capitalization of 11.5 billion yuan [3] Group 2 - For the year 2024, Boyuan Co., Ltd. reports that its revenue composition is entirely from the chemical industry, indicating a focused business model [2]

Market Outlook - The market for inorganic iodides is expected to grow significantly due to increasing medical expenditures driven by rising living standards, aging populations, and heightened health awareness [2][3] - The demand for contrast agents in the diagnosis of diseases such as tumors, cardiovascular diseases, and neurological disorders is projected to steadily increase, expanding the domestic contrast agent market [2][3] - The rapid development of the global pharmaceutical industry, particularly in new drug research and development, is expected to further drive the demand for high-quality pharmaceutical intermediates [3] Production Capacity Expansion - The company is establishing a new production project for 4,000 tons/year of inorganic iodides to enhance capacity and diversify its product offerings, focusing on high-value products for pharmaceutical and electronic applications [4] Competitive Advantages - **Resource Recycling and Service Integration**: The company has developed a unique "iodine resource recycling" industry chain, reducing reliance on imported iodine and lowering procurement costs while providing integrated solutions to clients [4] - **Regulatory Compliance and Scale**: As a leading iodine resource utilization enterprise, the company has a robust capacity for iodine recycling and complies with environmental regulations, enhancing collaboration with clients [4][5] - **Technological Innovation**: The company emphasizes continuous technological advancement and has established a comprehensive R&D and talent incentive system, leading to industry-leading processes and patented technologies [5] - **Quality Control and Client Relationships**: A thorough quality control system ensures product quality, with core products certified by authoritative bodies, fostering long-term trust with major clients [5] Shareholder Information - The company plans to release 19,630,000 shares from lock-up on December 11, 2025, with no current plans for shareholder reductions communicated [5]

Investment Rating - The report maintains an "Overweight" rating for the basic chemical industry [1][9]. Core Viewpoints - The basic chemical index outperformed the CSI 300 index by 2.93 percentage points, with a weekly increase of 2.50% compared to a decrease of 0.43% for the CSI 300 [3][15]. - Key sub-industries showing significant gains include potassium fertilizer (10.66%), fluorochemicals (7.24%), phosphorus fertilizer and phosphorus chemicals (6.60%), organic silicon (5.85%), and non-metallic materials III (3.75%) [16][19]. - The report highlights a positive trend in the vitamin market, with prices for Vitamin A and E increasing due to proactive price hikes by major producers, leading to heightened market activity [6][9]. Summary by Sections Market Trends - The basic chemical index increased by 2.50% over the past week, outperforming the CSI 300 index [15]. - The top-performing sub-industries included potassium fertilizer, fluorochemicals, and phosphorus chemicals [16]. Chemical Product Price Trends - The top five products with the highest weekly price increases were hydrochloric acid (Shandong) at 57.14%, NYMEX natural gas at 24.85%, concentrated nitric acid at 9.68%, and domestic vitamins E and A at 8.70% and 6.67% respectively [24][28]. - The products with the largest weekly price declines included POM (injection) at -14.06%, international butadiene at -11.64%, and coal tar at -7.29% [24][25]. Investment Recommendations - The report suggests focusing on several key sectors: refrigerants, chemical fibers, tire manufacturing, and agricultural chemicals, with specific companies highlighted for potential investment [9][45]. - Notable companies to watch include Jinshi Resources, Juhua Co., and Wanhu Chemical among others [9][45].

Group 1 - The core viewpoint of the article highlights that Boyuan Co., Ltd. (SZ 301617) is actively engaging with investors, indicating a focus on transparency and communication regarding its business operations [1] - Boyuan Co., Ltd. reported that its revenue composition for the year 2024 is entirely from the chemical industry, with a 100.0% share [2] - As of the latest update, Boyuan Co., Ltd. has a market capitalization of 12.3 billion yuan [2]

Group 1: Company Overview - The company, Shandong Boyuan Pharmaceutical Chemical Co., Ltd., has a stock code of 301617 and is referred to as Boyuan Co. [1] Group 2: Investor Relations Activity - The investor relations activity involved a specific audience survey and included participants from various financial institutions such as Nuode Fund, Changjiang Securities, and others [2] - The meeting took place on October 31, 2025, in the Boyuan Co. conference room [2] Group 3: Product Capacity and Applications - The company has an existing production capacity of 4,100 tons/year for iodide products, which include inorganic iodides like potassium iodide and sodium iodide, as well as organic iodides such as trimethyl iodide [2][3] - Iodine and its derivatives are crucial raw materials in medical, agricultural, industrial, and nutritional fields, with applications in X-ray contrast agents, disinfectants, and LCD/LED screen polarizers [3] Group 4: Strategic Partnerships - Boyuan Co. signed a strategic cooperation framework agreement with Dongsheng Technology in October 2025, focusing on resource integration and technological innovation to enhance competitiveness in the solid-state battery materials industry [2] Group 5: Global Iodine Market Insights - According to SQM's 2024 annual report, the downstream application structure of iodine shows that X-ray contrast agents, pharmaceutical manufacturing, and LCD panel manufacturing account for approximately 63% of global consumption [3] - The global iodine production is concentrated in Chile, Japan, and the USA, which together account for 88% of total sales, with Chilean companies alone contributing 60% of global iodine sales [3]

Group 1: Iodine and Its Applications - Iodine and its derivatives are crucial raw materials in medical, agricultural, industrial, and nutritional fields, widely used in various product formulations as key components or catalysts [2] - The downstream application structure of iodine includes three core areas: X-ray contrast agents, pharmaceutical manufacturing, and LCD panel manufacturing, which together account for approximately 63% of global consumption [2] - Major iodine production is concentrated in Chile, Japan, and the United States, with these three countries accounting for 88% of global sales [2][3] Group 2: Company Product Overview - The company’s inorganic iodide products include potassium iodide, potassium iodate, sodium iodide, hydriodic acid, and cuprous iodide, primarily used in pharmaceuticals, pesticides, feed, and optoelectronic materials [3] - Organic iodide products include trimethylsilyl iodide and methyl iodide, with trimethylsilyl iodide being used as a protecting group in organic synthesis, particularly in the production of antibiotics [3] Group 3: Strategic Developments - The company signed a strategic cooperation framework agreement with a technology partner in October 2025 to enhance the industrialization of sulfide solid electrolyte technology through resource integration and innovation [3] - The company’s 4000 tons/year inorganic iodide production project is expected to be completed by the end of 2025, with a production capacity of 300 tons of lithium iodide upon full operation [3]

Market Overview - The chemical products sector experienced a decline of 0.57% on the trading day, with Boyuan Co., Ltd. leading the losses [1] - The Shanghai Composite Index closed at 3986.9, down 0.73%, while the Shenzhen Component Index closed at 13532.13, down 1.16% [1] Stock Performance - Notable gainers in the chemical products sector included: - Hangzhou Oxygen Plant Co., Ltd. (002430) with a closing price of 29.52, up 9.99% and a trading volume of 494,700 shares, totaling 1.43 billion yuan [1] - Pioneer New Materials (300163) closed at 4.93, up 6.94% with a trading volume of 1,542,200 shares, totaling 759 million yuan [1] - Jinrongzi (002407) closed at 26.50, up 6.26% with a trading volume of 2,445,100 shares, totaling 6.408 billion yuan [1] - Major decliners included: - Boyuan Co., Ltd. (301617) closed at 94.00, down 7.66% with a trading volume of 78,600 shares, totaling 763 million yuan [2] - Jinhua New Materials (920015) closed at 58.33, down 7.29% with a trading volume of 132,100 shares, totaling 810 million yuan [2] - Poly United (002037) closed at 10.10, down 6.13% with a trading volume of 247,400 shares, totaling 254 million yuan [2] Capital Flow - The chemical products sector saw a net outflow of 933 million yuan from institutional investors, while retail investors contributed a net inflow of 665 million yuan [2] - The capital flow for specific stocks indicated: - Hangzhou Oxygen Plant Co., Ltd. had a net inflow of 1.52 billion yuan from institutional investors, while retail investors had a net outflow of 948.96 million yuan [3] - Yongtai Technology (002326) experienced a net inflow of 1.25 billion yuan from institutional investors, with a net outflow of 2.22 billion yuan from retail investors [3] - Yahua Group (002497) had a net inflow of 1.08 billion yuan from institutional investors, while retail investors saw a net outflow of 657.87 million yuan [3]

Market Overview - The chemical products sector increased by 1.38% on October 29, with JinHua New Materials leading the gains [1] - The Shanghai Composite Index closed at 4016.33, up 0.7%, while the Shenzhen Component Index closed at 13691.38, up 1.95% [1] Top Performers - JinHua New Materials (Code: 920015) closed at 62.92, up 30.00% with a trading volume of 135,600 shares and a turnover of 746 million [1] - WeiLan Bio (Code: 603739) closed at 15.51, up 10.00% with a trading volume of 96,900 shares and a turnover of 148 million [1] - YiNuoWei (Code: 920261) closed at 16.34, up 7.08% with a trading volume of 48,000 shares and a turnover of 75.93 million [1] Underperformers - XianFeng New Materials (Code: 300163) closed at 4.61, down 7.62% with a trading volume of 1,672,400 shares and a turnover of 787 million [2] - JinJi Co., Ltd. (Code: 300798) closed at 7.63, down 5.92% with a trading volume of 230,600 shares and a turnover of 178 million [2] - KaiLi New Materials (Code: 6888889) closed at 41.10, down 5.30% with a trading volume of 40,900 shares and a turnover of 170 million [2] Capital Flow - The chemical products sector experienced a net outflow of 84.36 million from institutional investors, while retail investors saw a net inflow of 87.49 million [2][3] - Major stocks like KaiMeiTeQi (Code: 002549) had a net inflow of 200 million from institutional investors, while DeMeiHuaGong (Code: 002054) saw a net outflow of 155 million [3]